Member Log-in

I forgot my password

Not a Member? Register

CHAI Shares High Level Review of Findings from New Procurement Assessment Framework

CHAI recently developed a review framework to help EPI programs better understand the disruptions and challenges pertaining to procurement that might result from Gavi transition and identify a way forward without compromising vaccine coverage. In close collaboration with EPI teams and partners, CHAI assessed current procurement processes and identified challenges along the following 4 dimensions – governance and regulations, planning, execution, and evaluation. We are pleased to share a high-level review of these findings. Looking ahead, CHAI is in the process of finalizing these assessments and they have begun co-developing with government multi-year mitigation plans. CHAI also intends to bring in-country lessons and test cases to the global level to inform policy and future investments. Please do not hesitate to reach out to CHAI for any questions or clarifications. 

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Practitioner Perspectives: Tbilisi Vaccine Procurement Workshop Interview Series – Dilorom Tursunova (1 of 4)

During our regional vaccine procurement workshop, which took place in Tbilisi, Georgia in April 2019, we sat down with a few participants to hear about their experiences related to topics ranging from vaccine forecasting, vaccine budgeting, and vaccine regulatory issues. This interview (first in a series of 4) is with Dilorom Tursunova, Deputy Chief of the … Continued

New Rotavirus Vaccine Prequalified by WHO

Bharat Biotech announced that ROTAVAC® has achieved pre-qualification by the World Health Organization (WHO), making it available for procurement by United Nations agencies and GAVI, the Vaccine Alliance, for use in low-resource countries. ROTAVAC is substantially cheaper than current rotavirus vaccines on the global market and will be available at $1/dose. Read more about ROTAVAC’s … Continued

New Guide Helps Countries Assess Immunization Financing Options

Helen Saxenian, Cheryl Cashin, and Paul Wilson, Results for Development Maintaining high rates of immunization coverage, which is essential for a persistent reduction in the incidence of vaccine-preventable infectious diseases, requires a sufficient and sustained investment. In order to ensure that governments are making adequate investments in immunization financing and are doing so through sustainable … Continued

Choose a Language